Navigation Links
Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
Date:10/4/2007

Data Safety Monitoring Board Recommends Continuing Study

NEW YORK, Oct. 4 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (Amex: IMM) announced today the completion of interim analysis of its Phase III pivotal clinical trial of Immtech's oral drug candidate, pafuramidine. An independent Data Safety Monitoring Board (DSMB) conducted the interim analysis and recommended that the trial should continue as planned. The trial is evaluating the safety and tolerability of pafuramidine, and comparing pafuramidine's efficacy to pentamidine, a non-oral drug, in treating Human African Tryanosomiasis (HAT), also know as African sleeping sickness.

African sleeping sickness is a fatal, vector-borne parasitic disease spread by tsetse flies that threatens approximately 60 million people in sub- Saharan Africa. Current treatments for the first stage of the disease include pentamidine and suramin. Both of these intravenous drugs are associated with reported toxic side effects. If approved, pafuramidine could become the first safe and effective oral treatment for first-stage African sleeping sickness.

Carol Olson, MD, PhD, Immtech's Sr. Vice President and Chief Medical Officer stated, "Successfully completing pafuramidine's Phase III interim analysis is a major milestone on the path to registering pafuramidine for treatment of African sleeping sickness. The next major milestone will be to have the remaining patients complete the 12-month follow up protocol and for Immtech to prepare the documents for the NDA submission. We aim to have pafuramidine approved to combat this devastating infectious disease."

Enrollment in this trial was completed earlier in 2007, and all patients are expected to complete
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... According to the new ... Systems- Warming & Cooling), Application (Acute & Perioperative ... Nursing & Paramedical Staff) - Global Forecasts & ... the global Temperature Management Market over the forecast ... expected to reach $2.5 Billion by 2019 at ...
(Date:9/18/2014)... --This BCC Research report discusses the medical device technologies in ... size, and opportunities for different devices and regions. It includes ... in the report focuses on technological trends in recent years ... and Japan . ... medical device technologies market. - Analyze market structure, including segments ...
(Date:9/18/2014)... FRANCISCO , Sept. 18, 2014   Fruit ... has secured an initial seed round of funding. ... investments, was led by a series of individual investors, ... investors whom participated in the initial round are; ... Valley Medical Center Urologist Stacy Childs, Rapha Family Medicine ...
Breaking Medicine Technology:Temperature Management Market Worth $2.5 Billion by 2019 2Temperature Management Market Worth $2.5 Billion by 2019 3Temperature Management Market Worth $2.5 Billion by 2019 4Medical Devices: Technologies and Global Markets 2Medical Devices: Technologies and Global Markets 3Medical Devices: Technologies and Global Markets 4Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3
(Date:9/19/2014)... Final Cut Pro X plugin and effects manufacturer, ... template for Apple's Final Cut Pro X . , ... FCPX users to create a professional themed video with ease ... Pixel Film Studios, "With 48 camera options and On-Screen controls, ... Theme." , Float features all of the tools needed ...
(Date:9/19/2014)... September 19, 2014 Yisrayl Hawkins, Pastor of ... expounding on the need to protect children. He begins by ... Michael Brown and reminds that there are many other children, ... says violence is spreading faster than cancer all over the ... “There are close to seven billion Michaels in the world ...
(Date:9/19/2014)... Angeles, California (PRWEB) September 19, 2014 There ... younger man for companionship and intimacy, and there are thousands ... with an experienced, mature woman. SeekingCougar.com now provides ... This online dating website caters to older women, and the ... an easy and convenient way for these people to meet ...
(Date:9/19/2014)... VogueQueen.com has recently unveiled a new ... more beautiful at their weddings. The new range has ... company’s new products are made for the coming autumn. ... all the global clients. , “The bridal ... ordered several items on its website. I'm very satisfied ...
(Date:9/18/2014)... Petersburg, FL (PRWEB) September 19, 2014 ... with patented ingredients made just for these issues in ... includes Matrixyl, Haloxyl and Eyeliss," says Kathy Heshelow, founder ... inflammation, improving circulation and boosting collagen, to improve the ... special eye serum for wrinkles, dark circles and ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases Float Theme for Final Cut Pro X Users 2Health News:Yisrayl Hawkins Says the Michael Brown Scenario Will Continue Without Swift Action in New Post 2Health News:Dating Site "SeekingCougar.com" Now Offering Tips for Younger Men Seeking Older Women 2Health News:VogueQueen.com’s New Line Of Cheap Wedding Dresses Aims To Attract Chic Ladies 2Health News:The Secret to Improving Under-Eye Skin: 30% Off Sale and Report on Ingredients Ends Tonight on the Face Whisperer® Advanced Eye Gel 2
... New England,s largest fertility clinics expands to 12 ... Science Center,(RSC) of New England, the seventh largest ... partnership with Lowell General Hospital with,the opening of ... North Chelmsford at 10 Research Place, Suite 250., ...
... of low-risk patients are almost always benign and do not ... patients. This finding is significant because incidental adrenal lesions ... say. , The study included 973 patients with 1,049 adrenal ... of a hormonally active adrenal mass, said Julie H. Song, ...
... for evaluation of small bowel pathologies (e.g., bleeding sources). ... time and reduced visibility by air and residual material. ... defoaming agents) have been tried to improve the quality ... has been recommended for bowel preparation for CE. , ...
... Na+/H+ exchanger (NHE1) is a transmembrane protein found in ... evacuate excessive H+ in the cytoplasm by means of ... of the upregulation of NHE-1 gene expression in human ... apoptosis of tumor cells, which is helpful for the ...
... Palmetto GBA, a,leading provider of technical and administrative services ... a retired Air Force,colonel and former executive with health ... board of directors., Shields, a resident of Isle ... for Louisville, Ky.-based Humana, where he had served as ...
... interferes with abnormal cell growth seen in pulmonary hypertension ... drug sorafenib (Nexavar) shows promise as a treatment for ... Center study. , During the study, nine patients took ... those given to cancer patients. The patients also continued ...
Cached Medicine News:Health News:Reproductive Science Center and Lowell General Hospital Announce Partnership in Infertility Treatment 2Health News:How does sodium phosphate combined with bisacodyl affect small intestine? 2Health News:Sorafenib Shows Promise for Heart-Lung Disease 2
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
... ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, ... 20-200 Inaccuracy (%) ... Imprecision(%) ... 1 Dimensions: ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: